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Leptin Resistance May Be the Link Between Obesity and CVD
High levels of circulating leptin are common in the obese and have been associatedwith insulin resistance and cardiovascular disease (CVD).But low levels of leptin
are associatedwith obesity and increased food intake in animals.Martin and colleagues
propose amodel where leptin resistancemay be tissue selective: central leptin resistance
lead to increased food intake and obesity, while elevated circulating leptin stimulates
pathways in peripheral tissues that predispose toCVD.Leptin resistancemay represent
a new diagnostic and therapeutic target in obesity-related CVD. See page 1201.
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Viewpoint and Commentary
Initiatives to Shorten Total Ischemic Time for STEMI
In their Viewpoint paper, Terkelsen and colleagues proffer that the 2007 UpdatedACC/AHA STEMI Guidelines unfairly penalize the transfer of patients to percu-
taneous coronary intervention (PCI)-capable hospitals. This is because the acceptable
time delay for primary PCI begins with emergency medical services arrival, but for
fibrinolysis the time delay begins with arrival to the hospital door. Antman responds in
aCommentary that the goal of both theD2B (Door toBalloon)Alliance and theAHA
Mission: Lifeline is to shorten total ischemic time by focusing on in-hospital processes
and comprehensive national initiatives, respectively. See pages 1211 and 1216.
See figure.
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Heart Rhythm Disorders
Changes in Atrial APD May Initiate or Propagate AF
Narayan and colleagues hypothesized that changes in the action potential duration(APD) of atrial cells near the pulmonary veins (PVs) may allow a single prema-
ture atrial contraction to initiate atrial fibrillation (AF). They measured changes in the
APD caused by changes in the diastolic interval (DI) from the prior beat. In patients
with paroxysmal AF, the APD shortened to a greater extent than the DI; in patients
with permanentAF the relativeAPD lengthened.This study reveals that changes in the
APD near PVs may explain both the initiation and propagation of AF. See page
1222. See figure.
(continued on page A-29)
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Heart Rhythm Disorders
Increased Frequency of J-Point Elevation in Patients With a History of VF
J-point elevation is usually an innocent finding in young individuals, but somereports suggest an association with idiopathic ventricular fibrillation (VF). Rosso
and colleagues performed a case-control study of 45 patients with idiopathic VF and 2
matched control groups. The J-point elevation was 3 times more common in those
with VF (42% vs. 13%), particularly for J-point elevation in the limb leads. The
finding of J-point elevation in an asymptomatic subject should not provoke an
extensive evaluation as the riskof having idiopathicVF is estimated tobe approximately
1 in 10,000. While J-point elevation in the limb leads is associated with VF, the
absolute risk of VF remains low. See page 1231. See figure.
Cardiac
Resynchronization Therapy
Patients With AF Benefit From CRT
Althoughone-thirdof advancedheart failure patients exhibit atrial fibrillation (AF),it is unclear if they benefit from cardiac resynchronization therapy (CRT).
Upadhyay and colleagues performed a meta-analysis comparing the outcomes for
patients in sinus rhythm (SR) and AF treated with CRT. Five studies with over 1,000
subjects were included. Both AF and SR patients benefited significantly from CRT,
with improvements in ejection fraction and in indices of quality of life. CRTappears to
be beneficial in patients with AF, widenedQRS, and left ventricular dysfunction, with
benefits similar to those seen for patients in SR. See pages 1239 and 1247.
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Cardiomyopathy
Poor Prognosis for Patients With Lamin A/C Mutations
Mutations in the lamin A/C (LMNA) gene have been associated with idiopathicdilated cardiomyopathy (DCM)plus atrioventricular block (AVB). Pasotti and
colleagues followed patients from 27 families in which at least 1 person was diagnosed
withDCMandhad anLMNAmutation.Of the 164 familymembers, 94were carriers
of LMNA gene mutations and 64% were phenotypically affected with a DCM.
During a median follow-up of 4.5 years, over 70% of the affected individuals experi-
enced an adverse event, mostly ventricular arrhythmias. By multivariable analysis,
New York Heart Association funcational class III to IV and a history of competing in
vigorous sports activity for 10 years were independent predictors of total events.
DCMs caused by the LMNA gene defects are highly penetrant, and result in adult-
onset DCM with high rates of ventricular arrhythmias. See pages 1250 and
1261. See figure.(continued on page A-32)
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Cardiac Imaging
DE-CMRI Can Quantify the Extent of Left Atrial Scarring After PVAI
McGann and colleagues describe a delayed enhancement cardiac magnetic reso-nance imaging (DE-CMRI) technique for detecting left atrial wall injury after
pulmonary vein antrum isolation (PVAI) procedures for atrial fibrillation (AF). Com-
paring pre- and 3-month post-magnetic resonance imaging images revealed that all
PVAI patients have some areas of the left atrium that display delayed enhancement.
There was a strong relationship between the degree of left atrial enhancement and
freedom from AF recurrence. DE-CMRI may be useful for quantifying the extent of
injury following PVAI and for defining the optimal locations for ablation energy.
See pages 1263 and 1272. See figure.
